Growth Metrics

Dolby Laboratories (DLB) Receivables - Other (2018 - 2025)

Dolby Laboratories (DLB) has disclosed Receivables - Other for 8 consecutive years, with $198.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Other fell 10.24% year-over-year to $198.3 million, compared with a TTM value of $198.3 million through Dec 2025, down 10.24%, and an annual FY2025 reading of $180.8 million, down 8.44% over the prior year.
  • Receivables - Other was $198.3 million for Q4 2025 at Dolby Laboratories, up from $180.8 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $275.3 million in Q1 2023 and bottomed at $97.5 million in Q3 2021.
  • Average Receivables - Other over 5 years is $188.9 million, with a median of $195.4 million recorded in 2023.
  • The sharpest move saw Receivables - Other tumbled 55.35% in 2022, then soared 164.17% in 2023.
  • Year by year, Receivables - Other stood at $226.8 million in 2021, then fell by 4.8% to $215.9 million in 2022, then grew by 0.76% to $217.6 million in 2023, then increased by 1.53% to $220.9 million in 2024, then dropped by 10.24% to $198.3 million in 2025.
  • Business Quant data shows Receivables - Other for DLB at $198.3 million in Q4 2025, $180.8 million in Q3 2025, and $204.4 million in Q2 2025.